The quadrivalent HPV vaccine (HPV4) is safe and highly efficacious, and can significantly reduce the burden of HPV-related genital warts and cancers among men, in addition to promoting herd immunity.

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

This would have made this vaccine India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. According to reports, there is already an existing vaccine in the private ...

India plans to roll out the HPV vaccine in the national immunization programme for school girls to protect them from cervical cancer “in a few months” time, top health ministry officials said Tuesday.

How accessible is the HPV vaccine in India ... Currently available quadrivalent and nonavalent vaccines are recommended for prevention of cervical cancer as well as some other HPV related diseases.

But rates of types 31/33/45, 47, and 45 were lower in vaccinated women, which the authors said suggests that the vaccines ...

In an interim analysis, the bivalent vaccine showed 90% efficacy for preventing CIN2+ associated with HPV 16 or 18. Recent reports have shown that a quadrivalent human papillomavirus (HPV ...

Understanding The Importance Of HPV Vaccine So far, there are six licensed HPV vaccines available worldwide, including bivalent, quadrivalent, and nonavalent options, according to the WHO.

Cervical cancer remains a major health challenge, but with widespread HPV vaccination and regular screening, we can work ...

Two global drug companies have teamed up with the GAVI Alliance to cut the price of cervical cancer vaccines to less than US$5 a dose in developing countries. The new record low price should mean ...